Bullous Pemphigoid and Intravenous Gammaglobulin
- 1 December 1985
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 103 (6_Part_1) , 965
- https://doi.org/10.7326/0003-4819-103-6-965_1
Abstract
To the editor: Bullous pemphigoid, a severe autoimmune blistering disease, is usually treated with high doses of corticosteroids, immunosuppressive drugs, or plasma exchange (1). Because high-dose intravenous gammaglobulin can alleviate various antibody-mediated diseases (2-5) we decided to try gammaglobulin in patients with bullous pemphigoid. Eleven patients with biopsy-proven bullous pemphigoid were studied. They were seven men and four women aged 64 to 82 years (mean, 70). All had IgG linear deposits along the basement membrane zone in perilesional skin, and six had serum antiepidermal antibodies (by indirect immunofluorescence). Nine patients received 0.4 g/kg body weight · d of intravenous polyvalentThis publication has 5 references indexed in Scilit:
- High-dose intravenous gamma globulin to suppress alloimmune destruction of donor plateletsThe American Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVISThe Lancet, 1984
- PLASMA EXCHANGE IN BULLOUS PEMPHIGOIDPublished by Elsevier ,1984
- High-Dose Intravenous Gamma Globulin for Autoimmune NeutropeniaNew England Journal of Medicine, 1982
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981